ArticleNano letters2025
Topology Determines DNA Origami Diffusion in Intestinal Mucus.
Article in Nano letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- From Blueprint to Breakthrough: How Far Can We Fold DNA Origami for Nano-Enabled Technologies?JACS Au · 2026Review
- Inflammation-specific DNA origami nanodevice for delivery of siRNAs to treat ulcerative colitis.Nature communications · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Efficient nanomedicine delivery across mucosal barriers remains a challenge due to the complex and poorly understood relationship between nanoparticle design and mucus transport. Here, we present DNA origami as a platform to investigate how the nanoparticle shape and ligand patterning influence diffusivity in mucus. By decoupling these parameters while maintaining identical material composition, we systematically evaluated the diffusion of rod, icosahedral, and rectangular nanostructures by using high-resolution single-particle tracking. Our results reveal that diffusivity in mucus is not solely determined by shape or functionalization alone but by their interplay: while unmodified rods diffused poorly, their mobility increased significantly upon antibody functionalization, reaching a maximum at an intermediate ligand density. In contrast, rods and icosahedra exhibited less pronounced and nonoptimal responses to surface modification. These findings highlight the importance of topology-specific optimization in nanoparticle design and demonstrate the utility of DNA nanotechnology to uncover design rules for next-generation mucus-penetrating drug delivery systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.